Merck is establishing a separate cancer unit. The reorganization of its pharmaceutical business is aimed at bolstering product launches ahead of a key patent loss.

3 weeks ago 19

The drugmaker is reorganizing to bolster merchandise launches up its crab cause Keytruda’s patent loss.